Offering opportunistic salpingectomy: implementation fundamentals

More than half of women who develop high-grade serous ovarian cancer had an earlier abdominal or pelvic operation where both Fallopian tubes could have been removed - a median of 30 years before diagnosis - and a third of those operations were general surgery.

Requiring a gynecology consult for every candidate does not scale: 44% of US counties have no practicing OB-GYN. The Michigan model, aligned with programs in British Columbia and at other US centers, trains surgeons to counsel eligible patients directly, supported by gynecologic champions at each site and by the Michigan Surgical Quality Collaborative (MSQC).

Phase 1 in Michigan focuses on appendectomy and non-cancer colorectal surgery (diverticular disease and similar indications) in women age 50 and older - operations already in or near the pelvis. Gallbladder surgery, despite being the most common eligible operation nationally, is deferred to a later phase because it requires different patient positioning. Robotic colorectal cases are a natural starting point: the added step typically takes about five minutes and no additional instruments.

Patient selection

A patient is a candidate for opportunistic salpingectomy when all of the following hold:

• Both Fallopian tubes are present and the planned operation provides reasonable access to the pelvis.
• Age 50 or older and undergoing planned appendectomy or colorectal surgery (Phase 1 criteria; younger patients involve additional considerations).
• No desire for future pregnancy. If the patient is uncertain, she is not a candidate - the procedure is permanent sterilization.
• Average risk. Known BRCA1/2 or another high-penetrance variant, or a strong family history of ovarian, breast, uterine, colon, or pancreatic cancer, should route to genetic counseling and gynecologic oncology instead; those patients have more protective options.

Counseling essentials

Use absolute and relative risk together: removal cuts the risk of high-grade serous ovarian cancer at least in half, from about 11 in 1,000 to about 5 in 1,000 lifetime for an average-risk woman. State plainly, and early, that natural pregnancy becomes impossible; IVF remains possible. Pair the menopause reassurance with its mechanism: the ovaries are left in place and make the hormones, so Fallopian tube removal has not been shown to change hormone function or the age of menopause.

The patient decision aid on this site is designed to support that conversation. It informs; it does not recommend. Patients can bring their downloaded summary to the preoperative visit.

Surgical conduct

The governing principle: the primary operation comes first, and the added step must not add risk.

1. Do not incur any additional risk to the patient. Abort the salpingectomy if pelvic adhesions, endometriosis, or limited visibility make it technically unsafe. Removing one tube or neither is an acceptable outcome.
2. Do not alter your surgical approach to the primary procedure in order to remove the Fallopian tubes.
3. Make an effort not to open additional instruments - monopolar energy, clips, and Endoloops can substitute for bipolar devices already off the field.
4. Remove both Fallopian tubes completely and retrieve them with a specimen bag through the trocar site.
5. Send both tubes for routine pathology. Separate right and left labeling is not required.
6. Document in the operative note whether both, one, or neither tube was removed, and tell the patient afterward.

Expected added operative time is minutes: an average of 13 minutes at gallbladder surgery in prospective data (range 4 to 45), about 4 minutes in British Columbia colorectal data, and 0 to 16 minutes at hysterectomy. Population data show no increase in complications, transfusions, readmissions, or reoperations. See the evidence page for the studies behind each figure.

Billing, coding, and coverage

Diagnosis coding: Z40.82 (encounter for prophylactic removal of Fallopian tubes, effective October 1, 2025) is the primary code for risk-reducing salpingectomy; add Z30.2 when sterilization is also part of the intent. Documentation should state that bilateral salpingectomy was performed prophylactically for ovarian cancer risk reduction in an average-risk patient, that the ovaries were preserved, and that the procedure was separately consented - a distinct operative field supports billing it as a distinct procedure.

Privileging and FPPE

Standard general-surgery privilege sets usually do not include adnexal surgery or salpingectomy, so plan a specific request through your medical staff office. The pathway MI-MAGIC recommends to Michigan hospitals:

1. Request the specific privilege (laparoscopy plus salpingectomy) through your institution’s delineation-of-privileges process.
2. Complete the MI-MAGIC training curriculum, then proctoring for your first one to two cases with an experienced salpingectomy surgeon.
3. FPPE: 100% chart review of your first five local cases within 12 months, against defined criteria - appropriate selection and consent, technique, specimen handling, and outcomes.

MI-MAGIC maintains a drafted FPPE template for laparoscopic opportunistic salpingectomy that medical staff offices can adapt. Request it at michigan-magic@umich.edu.

Training pathway

1. Apply for portal access with an active individual NPI associated with Michigan. A MI-MAGIC administrator reviews every application.
2. Complete the protected video curriculum: at least 90% viewing per required module, a knowledge check, and a versioned attestation.
3. Complete initial proctored cases with an experienced salpingectomy surgeon. The required number is being finalized with national partners.
4. Download your training completion record for your institution’s privileging process. The record documents completion only - it does not award CME credit or grant privileges.

Measurement through MSQC

A dedicated opportunistic salpingectomy data module in the MSQC registry, linked with claims data, will track uptake, safety, and equity across Michigan hospitals. This website collects no patient procedure or outcome data; measurement runs through MSQC's established infrastructure.

Common questions from surgeons